[ARTICLE] Therapeutic efficacy and safety of biweekly administration of enfortumab vedotin for urothelial carcinoma
DOI: 10.1093/jjco/hyae101
URL: https://pubmed.ncbi.nlm.nih.gov/39077841/
Posted Mar 8, 2025, 12:43 PM UTC
11
Loading comments…
DOI: 10.1093/jjco/hyae101
URL: https://pubmed.ncbi.nlm.nih.gov/39077841/
Posted Mar 8, 2025, 12:43 PM UTC